Cargando…

Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia

STUDY OBJECTIVES: Idiopathic hypersomnia (IH) is a chronic disorder characterized by excessive daytime sleepiness unexplained by another disorder or drug/medication use. Although the orexin system plays a role in sleep-wake regulation, orexin A levels in the cerebrospinal fluid are normal in people...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mignot, Emmanuel, Bogan, Richard K, Emsellem, Helene, Foldvary-Schaefer, Nancy, Naylor, Melissa, Neuwirth, Rachel, Faessel, Hélène, Swick, Todd, Olsson, Tina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Neurological Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485568/ https://www.ncbi.nlm.nih.gov/pubmed/36883238 http://dx.doi.org/10.1093/sleep/zsad049

Ejemplares similares

Orexin 2 receptor–selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients
por: Evans, Rebecca, et al.
Publicado: (2022)

Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
por: Bogan, Richard K, et al.
Publicado: (2020)

Mononucleosis: A Possible Cause of Idiopathic Hypersomnia
por: Sforza, Emilia, et al.
Publicado: (2018)

Idiopathic Hypersomnia—A Dynamic Simulation Model
por: Susta, Marek, et al.
Publicado: (2022)

Idiopathic Hypersomnia Patients Revealed Longer Circadian Period Length in Peripheral Skin Fibroblasts
por: Materna, Linus, et al.
Publicado: (2018)

Efficacy and Safety of Lower-Sodium Oxybate in an Open-Label Titration Period of a Phase 3 Clinical Study in Adults with Idiopathic Hypersomnia
por: Thorpy, Michael J, et al.
Publicado: (2022)

Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea
por: Malhotra, Atul, et al.
Publicado: (2019)

Long-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate
por: Schneider, Logan D, et al.
Publicado: (2023)

Comparing objective wakefulness and vigilance tests to on‐the‐road driving performance in narcolepsy and idiopathic hypersomnia
por: Bijlenga, Denise, et al.
Publicado: (2021)

Symptom Severity and Treatment Satisfaction in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE)
por: Schneider, Logan Douglas, et al.
Publicado: (2023)

Impairment in Functioning and Quality of Life in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE)
por: Stevens, Joanne, et al.
Publicado: (2023)

COVID-19 and Central Nervous System Hypersomnias
por: Frange, Cristina, et al.
Publicado: (2022)

Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial
por: Dauvilliers, Yves, et al.
Publicado: (2023)

Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study
por: Roy, Asim, et al.
Publicado: (2023)

Are unrefreshing naps associated with nocturnal sleep architecture specificities in idiopathic hypersomnia?
por: Mombelli, Samantha, et al.
Publicado: (2023)

Screening for idiopathic REM sleep behavior disorder: usefulness of actigraphy
por: Stefani, Ambra, et al.
Publicado: (2018)

A Practical Guide to the Therapy of Narcolepsy and Hypersomnia Syndromes
por: Mignot, Emmanuel J. M.
Publicado: (2012)

Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: a randomized clinical trial
por: Bogan, Richard K, et al.
Publicado: (2023)

IgG Abnormality in Narcolepsy and Idiopathic Hypersomnia
por: Tanaka, Susumu, et al.
Publicado: (2010)

Sodium oxybate in treatment-resistant rapid-eye-movement sleep behavior disorder
por: During, Emmanuel H, et al.
Publicado: (2023)

Comparison of the macro and microstructure of sleep in a sample of sleep clinic hypersomnia cases
por: Cairns, Alyssa, et al.
Publicado: (2019)

Phase and amplitude electroencephalography correlations change with disease progression in people with idiopathic rapid eye-movement sleep behavior disorder
por: Roascio, Monica, et al.
Publicado: (2021)

Hypersomnia
por: Dauvilliers, Yves, et al.
Publicado: (2005)

Kleine-Levin Syndrome and Idiopathic Hypersomnia: Spectrum Disorders
por: Gupta, Ravi, et al.
Publicado: (2011)

Manual Characterization of Sleep Spindle Index in Patients with Narcolepsy and Idiopathic Hypersomnia
por: DelRosso, Lourdes M., et al.
Publicado: (2014)

Pharmacokinetics, pharmacodynamics and safety assessment of multiple doses of soticlestat in healthy volunteers
por: Wang, Shining, et al.
Publicado: (2022)

Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjects
por: Wang, Shining, et al.
Publicado: (2021)

Evaluation of the Effect of Modafinil on Cognitive Functions in Patients with Idiopathic Hypersomnia with P300
por: Yaman, Mehmet, et al.
Publicado: (2015)

The melanopsin-mediated pupil response is reduced in idiopathic hypersomnia with long sleep time
por: Rach, Héloïse, et al.
Publicado: (2022)

Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility
por: Schweitzer, Paula K., et al.
Publicado: (2022)

A rare genetic variant in the cleavage site of prepro-orexin is associated with idiopathic hypersomnia
por: Miyagawa, Taku, et al.
Publicado: (2022)

O024 Sodium oxybate for refractory narcolepsy and idiopathic hypersomnia: clinical and employment outcomes
por: Hernest, A, et al.
Publicado: (2023)

Magnetic resonance imaging of Huntington's disease: preparing for clinical trials
por: Klöppel, S., et al.
Publicado: (2009)

Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder
por: Barber, Thomas R, et al.
Publicado: (2017)

Melatonin receptor type 1A gene linked to Alzheimer’s disease in old age
por: Sulkava, Sonja, et al.
Publicado: (2018)

Multiple treatment comparison in narcolepsy: a network meta-analysis
por: Lehert, Philippe, et al.
Publicado: (2018)

Changes in sleep duration and the risk of incident dementia in the elderly Japanese: the Ohsaki Cohort 2006 Study
por: Lu, Yukai, et al.
Publicado: (2018)

To split or to lump? Classifying the central disorders of hypersomnolence
por: Fronczek, Rolf, et al.
Publicado: (2020)

A circuit perspective on narcolepsy
por: Adamantidis, A R, et al.
Publicado: (2020)

Narcolepsy type 1: what have we learned from genetics?
por: Ollila, Hanna M
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3rcacst7bj5d3nc72bf3ioqmro